Uri Kopylov

63PUBLICATIONS
174CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersSurgeryCentral and Eastern European languages (incl. Russian)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Sep 09, 2026
Long-term real-world effectiveness and safety of mirikizumab in ulcerative colitis: 52-Week results from an expanded international two-center retrospective cohort study.

|Aug 05, 2026
Multimodal monitoring of pan-enteric mucosal healing and biologic persistence in Crohn's disease-the MILESTONE-CD prospective cohort.

|Jul 01, 2026
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

|Jun 15, 2026
Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.

|May 20, 2026
Inflammatory bowel disease phenotypes in diverse populations: a global comparative analysis.

|Nov 13, 2025
Mirikizumab in ulcerative colitis: real-world evidence from an international two-center retrospective cohort study.

Asaf Levartovsky, Martin Lukáš, Chaya Mushka Abitbol

Pageof 11

Frequent Collaborators

13 joint publications

Offir Ukashi

10 joint publications

Henit Yanai

7 joint publications

Bram Verstockt

7 joint publications

Shomron Ben-Horin